Suchergebnisse - "Li, Yanbai"

PubPharm (8)

1

Retraction for Li et al., "The current state of research on influenza antiviral drug development : drugs in clinical trial and licensed drugs"

enthalten in: mBio | 2024

von Li, Y. | Huo, S. | Yin, Z. | +5

RetractionOf: mBio. 2023 Oct 31;14(5):e0127323. - PMID 37610204

2

Retracted and republished from : "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs"

enthalten in: mBio | 2024

von Li, Y. | Huo, S. | Yin, Z. | +5

RepublishedFrom: mBio. 2023 Oct 31;14(5):e0127323. - PMID 37610204

3

The current state of research on influenza antiviral drug development : drugs in clinical trial and licensed drugs

enthalten in: mBio | 2023

von Li, Y. | Huo, S. | Yin, Z. | +5

RetractionIn: mBio. 2024 Mar 22;:e0010624. - PMID 38517163

4

Recent advances in developing small-molecule inhibitors against SARS-CoV-2

enthalten in: Acta pharmaceutica Sinica. B | 2022

von Xiang, R. | Yu, Z. | Wang, Y. | +9

5

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2

enthalten in: Signal transduction and targeted therapy | 2020

von Yu, F. | Xiang, R. | Deng, X. | +7

6

Influenza virus glycoprotein-reactive human monoclonal antibodies

enthalten in: Microbes and infection | 2020

von Li, Y. | Wang, L. | Si, H. | +7

7

Development of small-molecule inhibitors against hantaviruses

enthalten in: Microbes and infection | 2020

von Deng, X. | Tian, S. | Yu, Z. | +7

8

Development of Small-Molecule Inhibitors Against Zika Virus Infection

enthalten in: Frontiers in microbiology | 2019

von Wang, L. | Liang, R. | Gao, Y. | +7

1
[1]